Epidemiology module of practical skills for mbbs student


Study 4- Resistance to antituberculosis drugs in Cameroon



Yüklə 1,59 Mb.
səhifə68/113
tarix03.01.2022
ölçüsü1,59 Mb.
#52129
1   ...   64   65   66   67   68   69   70   71   ...   113

Study 4- Resistance to antituberculosis drugs in Cameroon



Setting: Tuberculosis centre in Hopital Jamot, Yaounde, the sole referral facility for tuberculosis treatment

Objectives: To identify strains of M tuberculosis responsible for pulmonary tuberculosis and to determine the prevalence of initial resistance to the main drugs used for treatment and to compare this prevalence between those HIV positive and HIV negative

Design: 576 consecutive, previously untreated, adult patients with smear positive pulmonary tuberculosis, admitted between July 1994 and December 1995 were studied. Standard species identification was carried out. Sputum was cultured on Lowenstein-Jensen and Coletsos media. Susceptibility of isolates to major drugs was tested using the indirect proportion method. HIV testing was performed with 2 ELISAs and confirmed with Western Blot.

Results: M. tuberculosis was isolated in 516 (90%) of the cases. Of the 516 cases, 92 (18%) were HIV positive. Of the 516 strains isolated, 164 (32%) were resistant to at least one drug. Resistance was noted as follows: 25% to one drug, 5.8% to 2 drugs, and 1% to three or more. Initial resistance was most frequent to Streptomycin (20.5%), followed by isoniazid (12.4%), rifampicin (0.8%) and ethambutol (0.4%). No significant difference was observed between HIV-positive and HIV-negative patients.

Conclusion: Initial drug resistance to M tuberculosis is relatively high in Yaounde.

Int J Tuberc Lung Dis 1997;1:110-114


Yüklə 1,59 Mb.

Dostları ilə paylaş:
1   ...   64   65   66   67   68   69   70   71   ...   113




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin